These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17693389)

  • 1. Attenuation of insulin secretion by insulin-like growth factor binding protein-1 in pancreatic beta-cells.
    Zhang F; Sjöholm Å; Zhang Q
    Biochem Biophys Res Commun; 2007 Oct; 362(1):152-157. PubMed ID: 17693389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells.
    Vieira E; Salehi A; Gylfe E
    Diabetologia; 2007 Feb; 50(2):370-9. PubMed ID: 17136393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for inhibitory autocrine effects of proinsulin C-peptide on pancreatic β-cell function and insulin secretion.
    McKillop AM; Ng MT; Abdel-Wahab YH; Flatt PR
    Diabetes Obes Metab; 2014 Oct; 16(10):937-46. PubMed ID: 24702738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+-secretion coupling is impaired in diabetic Goto Kakizaki rats.
    Rose T; Efendic S; Rupnik M
    J Gen Physiol; 2007 Jun; 129(6):493-508. PubMed ID: 17535961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The somatostatin receptor in human pancreatic β-cells.
    Braun M
    Vitam Horm; 2014; 95():165-93. PubMed ID: 24559918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of miR-132 and miR-212 Expression by Glucagon-Like Peptide 1 (GLP-1) in Rodent and Human Pancreatic β-Cells.
    Shang J; Li J; Keller MP; Hohmeier HE; Wang Y; Feng Y; Zhou HH; Shen X; Rabaglia M; Soni M; Attie AD; Newgard CB; Thornberry NA; Howard AD; Zhou YP
    Mol Endocrinol; 2015 Sep; 29(9):1243-53. PubMed ID: 26218441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival.
    Khan D; Vasu S; Moffett RC; Irwin N; Flatt PR
    Mol Cell Endocrinol; 2016 Nov; 436():102-13. PubMed ID: 27465830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein synthesis sequentially impairs distinct steps of stimulus-secretion coupling in pancreatic beta cells.
    Garcia-Barrado MJ; Ravier MA; Rolland JF; Gilon P; Nenquin M; Henquin JC
    Endocrinology; 2001 Jan; 142(1):299-307. PubMed ID: 11145593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual effect of cell-cell contact disruption on cytosolic calcium and insulin secretion.
    Jaques F; Jousset H; Tomas A; Prost AL; Wollheim CB; Irminger JC; Demaurex N; Halban PA
    Endocrinology; 2008 May; 149(5):2494-505. PubMed ID: 18218692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The imidazoline NNC77-0020 affects glucose-dependent insulin, glucagon and somatostatin secretion in mouse pancreatic islets.
    Høy M; Olsen HL; Bokvist K; Petersen JS; Gromada J
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):284-93. PubMed ID: 13680090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NNT reverse mode of operation mediates glucose control of mitochondrial NADPH and glutathione redox state in mouse pancreatic β-cells.
    Santos LRB; Muller C; de Souza AH; Takahashi HK; Spégel P; Sweet IR; Chae H; Mulder H; Jonas JC
    Mol Metab; 2017 Jun; 6(6):535-547. PubMed ID: 28580284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP-mediated and metabolic amplification of insulin secretion are distinct pathways sharing independence of β-cell microfilaments.
    Mourad NI; Nenquin M; Henquin JC
    Endocrinology; 2012 Oct; 153(10):4644-54. PubMed ID: 22948217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
    Gromada J; Ding WG; Barg S; Renström E; Rorsman P
    Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells.
    Gonzalez R; Reingold BK; Gao X; Gaidhu MP; Tsushima RG; Unniappan S
    J Endocrinol; 2011 Mar; 208(3):R9-R16. PubMed ID: 21224288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine regulation of glucokinase and ATP synthase sensitizes glucose-induced insulin secretion in pancreatic beta-cells.
    Yang J; Wong RK; Park M; Wu J; Cook JR; York DA; Deng S; Markmann J; Naji A; Wolf BA; Gao Z
    Diabetes; 2006 Jan; 55(1):193-201. PubMed ID: 16380493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and prediabetes.
    Irles E; Ñeco P; Lluesma M; Villar-Pazos S; Santos-Silva JC; Vettorazzi JF; Alonso-Magdalena P; Carneiro EM; Boschero AC; Nadal Á; Quesada I
    Mol Cell Endocrinol; 2015 Mar; 404():46-55. PubMed ID: 25633666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets.
    Li XN; Herrington J; Petrov A; Ge L; Eiermann G; Xiong Y; Jensen MV; Hohmeier HE; Newgard CB; Garcia ML; Wagner M; Zhang BB; Thornberry NA; Howard AD; Kaczorowski GJ; Zhou YP
    J Pharmacol Exp Ther; 2013 Feb; 344(2):407-16. PubMed ID: 23161216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.